BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20032097)

  • 1. Association between a CTGF gene polymorphism and systemic sclerosis in a French population.
    Granel B; Argiro L; Hachulla E; Fajardy I; Weiller PJ; Durand JM; Frances Y; Dombey AM; Marquet S; Lesavre N; Disdier P; Bernard F; Hatron PY; Chevillard C
    J Rheumatol; 2010 Feb; 37(2):351-8. PubMed ID: 20032097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
    Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
    Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis.
    Abdallah AM; Renzoni EA; Anevlavis S; Lagan AL; Munkonge FM; Fonseca C; Black CM; Briggs D; Wells AU; Marshall SE; McHugh N; du Bois RM; Welsh KI
    Int J Immunogenet; 2006 Jun; 33(3):155-61. PubMed ID: 16712644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma.
    Zhou X; Tan FK; Reveille JD; Wallis D; Milewicz DM; Ahn C; Wang A; Arnett FC
    Arthritis Rheum; 2002 Nov; 46(11):2990-9. PubMed ID: 12428242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-nucleotide polymorphisms in CCL2 gene are not associated with susceptibility to systemic sclerosis.
    Carulli MT; Spagnolo P; Fonseca C; Welsh KI; duBois RM; Black CM; Denton CP
    J Rheumatol; 2008 May; 35(5):839-44. PubMed ID: 18381789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
    Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
    Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in COL15 gene are not associated with systemic sclerosis.
    Pushpakom SP; Herrick AL; Kumar S; Worthington J
    J Rheumatol; 2008 Feb; 35(2):251-3. PubMed ID: 18203317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population.
    Wipff J; Allanore Y; Kahan A; Meyer O; Mouthon L; Guillevin L; Pierlot C; Glikmans E; Bardin T; Boileau C; Cornélis F; Dieudé P
    Ann Rheum Dis; 2006 Sep; 65(9):1230-2. PubMed ID: 16464986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
    Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study of a polymorphism of the CTGF gene and susceptibility to systemic sclerosis in the Japanese population.
    Kawaguchi Y; Ota Y; Kawamoto M; Ito I; Tsuchiya N; Sugiura T; Katsumata Y; Soejima M; Sato S; Hasegawa M; Fujimoto M; Takehara K; Kuwana M; Yamanaka H; Hara M
    Ann Rheum Dis; 2009 Dec; 68(12):1921-4. PubMed ID: 19054818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype.
    Rueda B; Simeon C; Hesselstrand R; Herrick A; Worthington J; Ortego-Centeno N; Riemekasten G; Fonollosa V; Vonk MC; van den Hoogen FH; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Gonzalez-Escribano MF; Coenen MJ; Lambert N; Nelson JL; Radstake TR; Martin J
    Ann Rheum Dis; 2009 Oct; 68(10):1618-20. PubMed ID: 19054816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients.
    Beretta L; Cappiello F; Moore JH; Barili M; Greene CS; Scorza R
    Arthritis Rheum; 2008 Jul; 59(7):974-83. PubMed ID: 18576303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis.
    Hutyrová B; Lukác J; Bosák V; Buc M; du Bois R; Petrek M
    J Rheumatol; 2004 Jan; 31(1):81-4. PubMed ID: 14705223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-nucleotide polymorphisms in the SPARC gene are not associated with susceptibility to scleroderma.
    Lagan AL; Pantelidis P; Renzoni EA; Fonseca C; Beirne P; Taegtmeyer AB; Denton CP; Black CM; Wells AU; du Bois RM; Welsh KI
    Rheumatology (Oxford); 2005 Feb; 44(2):197-201. PubMed ID: 15546965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variations in genes encoding RANK, RANKL, and OPG in rheumatoid arthritis: a case-control study.
    Assmann G; Koenig J; Pfreundschuh M; Epplen JT; Kekow J; Roemer K; Wieczorek S
    J Rheumatol; 2010 May; 37(5):900-4. PubMed ID: 20231205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis.
    Tsuchiya N; Kuroki K; Fujimoto M; Murakami Y; Tedder TF; Tokunaga K; Takehara K; Sato S
    Arthritis Rheum; 2004 Dec; 50(12):4002-7. PubMed ID: 15593213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A polymorphism in the CTGF promoter region associated with systemic sclerosis.
    Fonseca C; Lindahl GE; Ponticos M; Sestini P; Renzoni EA; Holmes AM; Spagnolo P; Pantelidis P; Leoni P; McHugh N; Stock CJ; Shi-Wen X; Denton CP; Black CM; Welsh KI; du Bois RM; Abraham DJ
    N Engl J Med; 2007 Sep; 357(12):1210-20. PubMed ID: 17881752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of potential interaction of chemokine genes in susceptibility to systemic sclerosis.
    Lee EB; Zhao J; Kim JY; Xiong M; Song YW
    Arthritis Rheum; 2007 Jul; 56(7):2443-8. PubMed ID: 17599774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta1 gene polymorphism in patients with systemic sclerosis.
    Sugiura Y; Banno S; Matsumoto Y; Niimi T; Yoshinouchi T; Hayami Y; Naniwa T; Ueda R
    J Rheumatol; 2003 Jul; 30(7):1520-3. PubMed ID: 12858451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the FAM167A-BLK region with systemic sclerosis.
    Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
    Arthritis Rheum; 2010 Mar; 62(3):890-5. PubMed ID: 20131239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.